Glycopyrrolate Injection
Product Images NDC 70069-014

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70069-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate 01

Chemical structure of glycopyrrolate, showing its molecular framework with atoms including carbon, hydrogen, oxygen, nitrogen, and bromine, along with the molecular formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

Glycopyrrolate 02

Glycopyrrolate Injection, USP 0.2 mg/mL single-dose vial label. The label states intramuscular or intravenous administration, contains benzyl alcohol, and includes manufacturer information for Somerset Therapeutics, LLC in Hollywood, FL. It specifies the product is not for use in newborns and provides space for lot and expiration dates.*

FDA Label Image

Glycopyrrolate 03

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL by Somerset Therapeutics, LLC. It is a human prescription injection for intramuscular or intravenous use, supplied as 25 single-dose vials of 1 mL each. The label includes storage instructions, ingredients, and a barcode.*

FDA Label Image

Glycopyrrolate 04

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) intended for intramuscular or intravenous administration. The label indicates a 2 mL single-dose vial containing benzyl alcohol as a preservative. Manufactured by Somerset Therapeutics, LLC in Hollywood, FL, product code TN/Drugs/TN00003457, made in India. Includes bar code and standard regulatory information.*

FDA Label Image

Glycopyrrolate 05

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) in a carton of 25 single-dose vials. The label states it is for intramuscular or intravenous administration and is not for use in newborns. Manufactured for Somerset Therapeutics, LLC and made in India by Caplin Steriles Limited. Includes storage instructions and a barcode.*

FDA Label Image

Glycopyrrolate 06

Glycopyrrolate Injection USP 1 mg/5 mL (0.2 mg/mL) multiple dose vial label for intramuscular or intravenous administration. Contains benzyl alcohol preservative, not for use in newborns. Manufactured for Somerset Therapeutics, LLC, Hollywood, FL. Additional storage and dosage instructions are included on the label.*

FDA Label Image

Glycopyrrolate 07

The packaging label for Glycopyrrolate Injection, USP, 1 mg/5 mL (0.2 mg/mL) by Somerset Therapeutics, LLC. The label indicates it is for intramuscular or intravenous administration, contains benzyl alcohol as a preservative, and includes storage instructions at 20° to 25°C. The label also states it is not for use in newborns and provides manufacturer details and barcode information.*

FDA Label Image

Glycopyrrolate 08

Label for Glycopyrrolate Injection, USP 0.4 mg/20 mL (0.2 mg/mL) multiple dose vial by Somerset Therapeutics, LLC. The label notes the product contains benzyl alcohol, is for intramuscular or intravenous use, and includes warnings such as not for use in newborns. Storage instructions specify 20° to 25°C (68° to 77°F). The product is manufactured in India.*

FDA Label Image

Glycopyrrolate 09

Packaging label for Glycopyrrolate Injection, USP, 0.2 mg/mL (4 mg/20 mL) in 10 x 20 mL multiple dose vials by Somerset Therapeutics, LLC. The label includes dosage form as injection for intramuscular or intravenous use, contains benzyl alcohol as preservative, and includes storage instructions at 20° to 25°C (68° to 77°F). It also notes it is not for use in newborns and that it is manufactured by Caplin Steriles Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.